

|
Email:
|
lucia.klimcakova@upjs.sk | |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/lucia.klimcakova | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
ULBL
-
Department of Medical Biology
|
|
|
Office:
|
MA5O516 | |
|
Phone:
|
+421 55 234 3227 | |
|
ORCID ID:
|
0000-0002-8004-9140 |
|
Profile courses
|
|
Biológia 1, I.+II. degree
|
|
Biology 1, I.+II. degree
|
|
Biológia 2, I.+II. degree
|
|
Biology 2, I.+II. degree
|
|
Selected publications
|
|
V3 - Koľvek G., Klimčáková L., Hrčková G., Židzik J., Podracká Ľ., Baltesová T., Kubejová K., Rosenberger J., Barkai L.: High Prevalence of Autosomal Recessive Alport Syndrome in Roma Population of Eastern Slovakia. Biomedicines, 2025(13), s. 1-12, IF 4.500, Q2. Cited: 1x |
|
V3 - Jarčušková D., Tkáč I., Hlaváčová N., Yaluri A., Kozárová M., Habalová V., Klimčáková L., Židzik J., Javorský M., Bednářová A.: Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder. BMC Psychiatry, 2024(24), s. 1-7, IF 3.600, Q1. Cited:16x |
|
P1 - Slabá E., Židzik J., Solár P., Mičková H., Šalagovič J., Hudáková T., Habalová V., Klimčáková L., Šemeláková M.: Lekárska biológia a genetika. 1. vyd. Košice: Univerzita Pavla Jozefa Šafárika v Košiciach, 2023. 354 s. ISBN 9788057401773. |
|
Selected projects
|
|
VEGA 1/0050/24: Investigation of selected gene variants in relation to the effect of GLP-1 receptor agonists on the reduction of HbA1c and body weight in type 2 diabetes. Co-investigator. The project manager: prof. MUDr. Ivan Tkáč, PhD. Project duration: 2024-2027 |
|
KEGA 024UPJŠ-4/2024: Introduction of practical biomedical research courses for doctoral students and integration of research staff into new "PraktikMed" teaching approaches. Co-investigator. The project manager: doc. RNDr. Peter Solár, PhD. Project duration: 2024-2026 |
|
VEGA 1/0534/23: Targeted genetic screening in patients with Alport phenotype. Deputy Project Leader. The project manager: doc. MUDr. Gabriel Koľvek, PhD. Project duration: 2023-2025 |
|
VEGA 1/0183/20: Monitoring of genomic and proteomic markers of progression of the atherosclerosis in limb and carotid arteries in type 2 diabetes patients. Co-investigator. The project manager: prof. MUDr. Ivan Tkáč, PhD. Project duration: 2020-2023 |
|
MZ 2019/29-UPJŠ-1: Monitoring the relationship of selected gene variants and proteomic markers in patients with mental disorders as a contribution to their personalized treatment. Co-investigator. The project manager: MUDr. Miriam Kozárová, PhD. Project duration: 2019-2022 |
|
International mobilities and visits
|
|
University of Iceland, Faculty of Medicine, Reykjavik, Iceland, 20. - 25.5.2024, EEA and Norway Grants
|
|
Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, Spain, 2002 – 2003, Marie Curie Fellowship, EU FP5
|
